Background and insight
MedicalXpress describes an early study by researchers at City of Hope and collaborators. They have developed a therapy containing 16 carefully selected beneficial bacteria intended to restore the microbiome and counter harmful microbes. It is being studied as a way to prevent serious bloodstream infections in people with blood cancers who receive stem cells from a donor.
The microbiome is the community of microorganisms living in places such as the gut. Cancer treatment and stem cell transplantation can leave patients especially vulnerable to infection. The approach aims to support the body’s natural microbial defences, but this is an early-stage study. The therapy should not be described as an established cure, and its results cannot yet be assumed to apply to other groups.
What does this mean for your everyday life?
This is not a treatment that most healthy people should try to replicate. It is a research approach for a particularly vulnerable patient group, and bacteria-based products or supplements may pose risks when the immune system is weakened. For patients and families, the news may be encouraging, but it is important to ask the care team what is established and whether any relevant trials are available.
💡 How to use this knowledge
- If you or someone close to you is having a stem cell transplant, ask the transplant team how infections are prevented and which symptoms require urgent contact.
- Do not start probiotics, supplements or other “microbiome treatments” during cancer care without checking with the treating doctor. Bring the product name and ingredient list to the appointment.
- When reading about promising treatments, check whether the evidence comes from an early trial, how many people took part, and whether the treatment is approved or still being studied.